WallStreetZenWallStreetZen

NASDAQ: PIII
P3 Health Partners Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PIII

Based on 1 analyst offering 12 month price targets for P3 Health Partners Inc

Min Forecast
$12.50+547.67%
Avg Forecast
$12.50+547.67%
Max Forecast
$12.50+547.67%

Should I buy or sell PIII stock?

Based on 1 analyst offering ratings for P3 Health Partners Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PIII stock forecasts and price targets.

PIII stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-17

1 of 1

Forecast return on equity

Is PIII forecast to generate an efficient return?

Forecast return on assets

Is PIII forecast to generate an efficient return on assets?

Company
-0.28%
Industry
10.01%
PIII is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PIII earnings per share forecast

What is PIII's earnings per share in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$21.19
Avg 2 year Forecast
-$0.27

PIII revenue forecast

What is PIII's revenue in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$1.7B+16.13%
Avg 2 year Forecast
$1.7B+14.26%
PIII's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PIII revenue growth forecast

How is PIII forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
16.13%
Industry
9.3%
Market
1,548.07%
PIII's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PIII's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PIII vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
PIII$1.93$12.50+547.67%Strong Buy
AMS$2.18N/AN/A
BMGL$0.64N/AN/A
CCM$3.97N/AN/A
SRXH$0.14N/AN/A
View Top Medical Care Facility Stocks

P3 Health Partners Stock Forecast FAQ

Is P3 Health Partners Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PIII) stock is to Strong Buy PIII stock.

Out of 1 analyst, 1 (100%) are recommending PIII as a Strong Buy, 0 (0%) are recommending PIII as a Buy, 0 (0%) are recommending PIII as a Hold, 0 (0%) are recommending PIII as a Sell, and 0 (0%) are recommending PIII as a Strong Sell.

If you're new to stock investing, here's how to buy P3 Health Partners stock.

What is PIII's earnings growth forecast for 2026-2027?

(NASDAQ: PIII) P3 Health Partners's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 32.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,345.06%.

P3 Health Partners's earnings in 2026 is -$131,046,000.On average, 5 Wall Street analysts forecast PIII's earnings for 2026 to be -$152,653,285, with the lowest PIII earnings forecast at -$190,165,582, and the highest PIII earnings forecast at -$110,537,338.

In 2027, PIII is forecast to generate -$1,910,922 in earnings, with the lowest earnings forecast at -$1,835,984 and the highest earnings forecast at -$1,967,126.

What is PIII's revenue growth forecast for 2026-2027?

(NASDAQ: PIII) P3 Health Partners's forecast annual revenue growth rate of 16.13% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 9.3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,548.07%.

P3 Health Partners's revenue in 2026 is $1,444,952,000.On average, 5 Wall Street analysts forecast PIII's revenue for 2026 to be $12,090,978,342, with the lowest PIII revenue forecast at $11,413,652,976, and the highest PIII revenue forecast at $12,653,014,284.

In 2027, PIII is forecast to generate $11,896,427,439 in revenue, with the lowest revenue forecast at $11,435,269,743 and the highest revenue forecast at $12,249,501,300.

What is PIII's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: PIII) forecast ROA is -0.28%, which is lower than the forecast US Medical Care Facilities industry average of 10.01%.

What is PIII's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PIII price target, the average PIII price target is $12.50, with the highest PIII stock price forecast at $12.50 and the lowest PIII stock price forecast at $12.50.

The Wall Street analyst predicted that P3 Health Partners's share price could reach $12.50 by Nov 17, 2026. The average P3 Health Partners stock price prediction forecasts a potential upside of 547.67% from the current PIII share price of $1.93.

What is PIII's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: PIII) P3 Health Partners's current Earnings Per Share (EPS) is -$41.68. On average, analysts forecast that PIII's EPS will be -$21.19 for 2026, with the lowest EPS forecast at -$26.39, and the highest EPS forecast at -$15.34. In 2027, PIII's EPS is forecast to hit -$0.27 (min: -$0.25, max: -$0.27).

What is PIII's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: PIII) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.